Evaluation and management of infertility in women: The internists' role

Annals of Internal Medicine

Volumn 132, Issue 12, 2000, Pages 973-981

  Rosene Montella, Karen ^a   Keely, Erin ^b   Laifer, Steven A ^c   Lee, Richard V ^d  

^a BROWN UNIVERSITY   (United States)

^b UNIVERSITY OF OTTAWA   (Canada)

^c BRIDGEPORT HOSPITAL   (United States)

^d UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMORBIDITY; FEMALE; FEMALE INFERTILITY; HUMAN; INFERTILITY THERAPY; INTERNAL MEDICINE; MEDICAL SPECIALIST; MULTIPLE PREGNANCY; PATIENT COUNSELING; PREGNANCY COMPLICATION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT;

EID: 0034691234     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-132-12-200006200-00008     Document Type: Review

References (60)

1. Wilcox LS, Mosher WD. Use of infertility services in the United States. Obstet Gynecol. 1993;82:122-7.
2. Speroff L, Glass RH, Kase NG. Female infertility. In: Clinical Gynecologic Endocrinology and Infertility. Speroff L, Glass RH, Kase NG. Baltimore: Lippincott Williams & Wilkins; 1999:1013-55.
3. Marsh M, Ronner W. The Empty Cradle: Infertility in America from Colonial Times to the Present. Baltimore: Johns Hopkins Univ Pr; 1996;1-6, 210-55.
4. Adashi EY, Hennebold JD. Single-gene mutations resulting in reproductive dysfunction in women. N Engl J Med. 1999;340:709-18.
5. Hoxsey R, Rinehart JS. Infertility and subsequent pregnancy. Clin Perinatol. 1997;24:321-42.
6. Healy DL, Trounson AO, Andersen AN. Female infertility: causes and treatment. Lancet. 1994;343:1539-44.
7. Lukse MP, Vacc NA. Grief, depression, and coping in women undergoing infertility treatment. Obstet Gynecol. 1999;93:245-51.
8. Teitze C. Reproductive span and rate of reproduction among Hutterite women. Fertil Steril. 1957;8:89-97.
9. Navot D, Drews MR, Bergh PA, Guzman I, Karstaedt A, Scott RT Jr, et al. Age-related decline in female fertility is not due to diminished capacity of the uterus to sustain embryo implantation. Fertil Steril. 1994;61:97-101.
10. Gilbert WM, Nesbitt TS, Danielsen B. Childbearing beyond age 40: pregnancy outcome in 24,032 cases. Obstet Gynecol. 1999;93:9-14.
11. Sauer MV, Paulson RJ, Lobo RA. Pregnancy in women 50 or more years of age: outcomes of 22 consecutively established pregnancies from oocyte donation. Fertil Steril. 1995;64:111-5.
12. Marshall LA. Caring for the infertile female patient and her partner. IM Internal Medicine. 1994;15:18-41.
13. Steptoe PC, Edwards RG, Purdy JM. Clinical aspects of pregnancies established with cleaving embryos grown in vitro. Br J Obstet Gynaecol. 1980;87: 757-68.
14. Borini A, Bafaro G, Violini F, Blanchi L, Casadio V, Flamigni C. Pregnancies in postmenopausal women over 50 years old n an oocyte donation program. Fertil Steril. 1995;63:258-61.
15. Paulson RJ, Thornton MH, Francis MM, Salvador HS. Successful pregnancy in a 63-year-old woman. Fertil Steril. 1997;67:949-51.
16. Annas GJ. The shadowlands - secrets, lies, and assisted reproduction. N Engl J Med. 1998;339:935-9.
17. Callahan TL, Hall JE, Ettner SL, Christiansen CL, Greene MF, Crowley WF Jr. The economic impact of multiple-gestation pregnancies and the contribution of assisted-reproduction techniques to their incidence. N Engl J Med. 1994;331:244-9.
18. Visscher RD. Economic implications of assisted reproductive technology N Engl J Med. 1994;331:1588-9.
19. Wilcox AJ, Baird DD, Weinberg CR. Time of implantation of the conceptus and loss of pregnancy. N Engl J Med. 1999;340:1796-9.
20. Parikh FR, Nadkarni SG, Kamat SA, Naik N, Soonawala SB, Parikh RM. Genital tuberculosis - a major pelvic factor causing infertility in Indian women. Fertil Steril. 1997;67:497-500.
21. Mandel SJ, Larsen PR, Seely EW, Blent GA. Increased need for thyroxine during pregnancy in women with primary hypothyroidism. N Engl J Med. 1990;323:91-6.
22. Hanson RG, Powrie RO, Lawson L. Diabetes insipidus in pregnancy: a treatable cause of oligohydramnios. Obstet Gynecol. 1997;89(5 Pt 2):815-7.
23. Kallen BA, Carlsson SS, Bengtsson BK. Diabetes insipidus and use of desmopressin (Minirin) during pregnancy. Eur J Endocrinol. 1995;132:144-6.
24. Zawadsky JK, Dunaif A. Polycystic ovary syndrome. In: Dunaif A, Givens JR, Haseltine FP, Merriam GR, eds. Boston Blackwell Scientific; 1992:377-84.
25. Franks S. Polycystic ovary syndrome. N Engl J Med. 1995;333:853-61.
26. Buyalos RP, Lee CT. Polycystic ovary syndrome: pathophysiology and outcome with in vitro fertilization. Fertil Steril. 1996;65:1-10.
27. Dunaif A. Insulin action in the polycystic ovary syndrome. Endocrinol Metab Clin North Am. 1999;28:341-59.
28. Dunaif A, Segal KR, Futterweit W, Dobrjansky A. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes. 1989;38:1165-74.
29. Dale PO, Tanbo T, Haug E, Abyholm T. The impact of insulin resistance on the outcome of ovulation induction with low-dose follicle stimulating hormone in women with polycystic ovary syndrome. Hum Reprod. 1998;13: 567-70.
30. Ehrmann DA. Insulin-lowering therapeutic modalities for polycystic ovary syndrome. Endocrinol Metab Clin North Am. 1999;28:423-38.
31. Legro RS, Kunselman AR, Dodson WC, Dunaif A. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab. 1999;84:165-9.
32. Lesser KB, Garcia FA. Association between polycystic ovary syndrome and glucose intolerance during pregnancy. J Matern Fetal Med. 1997;6:303-7.
33. Amowitz LL, Sobel BE. Cardiovascular consequences of polycystic ovary syndrome. Endocrinol Metab Clin North Am. 1999;28:439-58.
34. Dahlgren E, Johansson S, Lindstedt G, Knutsson F, Oden A, Janson PO, et al. Women with polycystic ovary syndrome wedge resected in 1956 to 1965: a long-term follow-up focusing on natural history and circulating hormones. Fertil Steril. 1992;57:505-13.
35. Wolfe HM, Gross TL. Obesity in pregnancy. Clin Obstet Gynecol. 1994;37: 596-604.
36. Anasti JN. Premature ovarian failure an update. Fertil Steril 1998;70:1-15.
37. Nelsen LM, Anasti JN, Kimzey LM, Defensor RA, Lipetz KJ, White BJ, et al. Development of luteinized graafian follicles in patients with karyotypically normal spontaneous premature ovarian failure. J Clin Endocrinol Metab 1994;79:1470-5.
38. Simpson JL. Genetic forms of gonadal dysgenesis in 46xx and 46xy individuals. Semin Reprod Endocrinol 1983;1:93.
39. Price WH, Clayton JF, Collyer S, De Mey R, Wilson J. Mortality ratios, life expectancy, and causes of death in patients with Turner's syndrome. J Epidemiol Community Health. 1986;40:97-102.
40. Birdsall M, Kennedy S. The risk of aortic dissection in women with Turner syndrome [Letter]. Hum Reprod. 1996;11:1587.
41. Press F, Shapiro HM, Cowell CA, Oliver GD. Outcome of ovum donation in Turner's syndrome patients. Fertil Steril. 1995;64:995-8.
42. Shahin MS, Puscheck E. Reproductive sequelae of cancer treatment. Obstet Gynecol Clin North Am. 1998;25:423-33.
43. Govaerts I, Devreker F, Delbaere A, Revelard P, Englert Y. Short-term medical complications of 1500 oocyte retrievals for in vitro fertilization and embryo transfer. Eur J Obstet Gynecol Reprod Biol. 1998;77:239-43.
44. Beerendonk CC, van Dop PA, Braat DD, Merkus JM. Ovarian hyperstimulation syndrome: facts and fallacies. Obstet Gynecol Surv. 1998;53:439-49.
45. Stewart JA, Hamilton PJ, Murdoch AP. Thromboembolic disease associated with ovarian stimulation and assisted conception techniques. Hum Reprod 1997;12:2167-73.
46. Ellis MH, Nun IB, Rathaus V, Werner M, Shenkman L. Internal jugular vein thrombosis in patients with ovarian hyperstimulation syndrome. Fertil Steril. 1998;69:140-2.
47. Hwang WJ, Lai ML, Hsu CC, Hou NT. Ischemic stroke in a young woman with ovarian hyperstimulation syndrome. J Formos Med Assoc. 1998;97:503-6.
48. Simon A, Revel A, Hurwitz A, Laufer N. The pathogenesis of ovarian hyperstimulation syndrome: a continuing enigma. J Assist Reprod Genet. 1998;15:202-9.
49. van de Vrie W, Baggen MG, Visser W, Derkx FH, Morrel B, Ouwendijk RJ. High renin and prorenin in plasma and pleural exudate of a patient with the ovarian hyperstimulation syndrome. Neth J Med 1997;51:232-6.
50. Levin ER, Rosen GF, Cassidenti DL, Yee B, Meldrum D, Wisot A, et al. Role of vascular endothelial cell growth factor m ovarian hyperstimulation syndrome. J Clin Invest. 1998;102:1978-85.
51. Pellicer A, Albert C, Mercader A, Bonilla-Musoles F, Remohi J, Simon C. The pathogeresis of ovarian hyperstimulation syndrome: in vivo studies investigating the role of interleukin-1β, interleukin-6, and vascular endothelial growth factor. Fertil Steril. 1999;71:482-9.
52. Abramov Y, Elchalal U, Schenker JG. Obstetric outcome of in vitro fertilized pregnancies complicated by severe ovarian hyperstimulation syndrome a multicenter study. Fertil Steril. 1998;70:1070-6.
53. Bamford PM, Steele SJ. Uterine and ovarian carcinoma in a patient receiving gonadotrophin therapy. Case report Br J Obstet Gynaecol. 1982;89: 962-4.
54. Ron E, Lunenfeld B, Menczer J, Blumstein T, Katz L, Oelsner G, et al. Cancer incidence in a cohort of infertile women. Am J Epidemiol. 1987;125: 780-90.
55. Whittemore AS, Harris R, Itnyre J. Characteristics relating to ovarian cancer risk collaborative analysis of 12 US case-control studies. I. Invasive epithelial cancers in white women. Collaborative Ovarian Cancer Group. Am J Epidemiol. 1992;136:1184-203.
56. Rossing MA, Daling JR, Weiss NS, Moore DE, Self SG. Ovarian tumors in a cohort of infertile women. N Engl J Med. 1994;331:771-6.
57. Shushan A, Paltiel O, Iscovich J, Elchalal U, Peretz T, Schenker JG. Human menopausal gonacotropin and the risk of epithelial ovarian cancer. Fertil Steril. 1996;65:13-8.
58. Piper JM, Ray WA, Rosa FW. Pregnancy outcome following exposure to angiotensin-converting enzyme inhibitors. Obstet Gynecol. 1992;80(3 Pt 1): 429-32.
59. Delgado-Escueta AV, Janz D. Consensus guidelines: preconception counseling, management, and care of the pregnant woman with epilepsy. Neurology. 1992;42(4 Suppl 5):149-60.
60. Greene MF, Hare JW, Cloherty JP, Benacerraf BR, Soeldner JS. First-trimester hemoglobin A1 and risk for major malformation and spontaneous abortion in diabetic pregnancy. Teratology. 1989;39:225-31.